Case study
Experiences with the MCV 5-dose Switch from Africa’s EPI
This video series features EPI managers, along with UNICEF and WHO regional leads, sharing firsthand experiences from countries that have transitioned from 10-dose to 5-dose measles-containing vaccine (MCV) vials for routine immunization. Speakers discuss why countries have pursued the switch, how transitions were planned and implemented, and observed impacts on vaccination coverage, session frequency, wastage, and program efficiency.
The interviews were recorded by UNICEF ESARO during the 2023 EPI Managers’ Meeting in Addis Ababa, with additional follow-up discussions conducted at the UNICEF Regional Office in Kenya. This resource is useful for early-phase orientation and peer learning, helping country teams understand the rationale for the switch and anticipate implementation considerations.
Authors
Languages
- English
Publication year
2024
Type
Case study
Categories
- Vaccines & delivery devices
Diseases
- Measles
- Rubella
Tags
- Vaccine presentation and packaging
WHO Regions
- African Region
MCV5 PHASE 1
You can find more information about "MCV5 PHASE 1" in the following Hot Topics:
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Measles and Measles-Rubella (MR) Vaccine Five-Dose Vial Presentation - Fact Sheet 2022 - 2023 | UNICEF, World Health Organization (WHO) | 2022 | Guidance | English |
| MCV 5-dose Research and Resources | Linksbridge | 2022 | Report | English |
| MCV 5-dose National Impact Assessment Tool | Linksbridge | 2026 | Tool | English, French |
| Experiences with the MCV 5-dose Switch from Africa’s EPI | UNICEF | 2024 | Case study | English |
| How To Use: Step-by-Step Instructions for the MCV 5-dose National Impact Assessment Tool | Linksbridge | 2025 | User guide | English |
| MCV 5-dose Option Overview | Linksbridge | 2026 | Guidance | English |
| MCV 5-dose 2-Pager | Linksbridge | 2026 | Guidance | English |
